Open access peer-reviewed chapter

Obesity and Gut Microbiota

Written By

Arslan Ahmad, Sakhawat Riaz and Muhammad Tanveer

Submitted: 24 April 2022 Reviewed: 12 May 2022 Published: 24 June 2022

DOI: 10.5772/intechopen.105397

From the Edited Volume

Effect of Microbiota on Health and Disease

Edited by Hoda El-Sayed

Chapter metrics overview

220 Chapter Downloads

View Full Metrics

Abstract

Obesity is a severe worldwide health problem driven by both hereditary and environmental factors, and its prevalence is increasing year after year. According to current thinking, The bacteria in the stomach may have a part in the growth of obesity and other health comorbidities. To better fully comprehend the link between obesity but also microbiomes, we sum up the features of the intestinal microbiota in obese people, the metabolic pathway of obesity-induced by the intestinal microbiota, and the impact of biological factors on the intestinal microbiota and adiposity in this chapter. The microbiome has been shown to have a major role in the development of obesity by regulating energy metabolism. The makeup and density of intestinal flora can be influenced by diet. Simultaneously, it is suggested that the gut microbiome be used in obesity studies. Some food items have recently shown that pro capability via functional ingredients that impact the intestinal flora, attracting the interest of scientists.

Keywords

  • obesity
  • weight loss
  • intestinal microbiota
  • diets

1. Introduction

Obesity is a physiological condition triggered by a mixture of hereditary and nongenetic variables, such as external cues. Obesity is classified by the World Health Organization as having a Body fat percentage of more than 30, however, the requirements vary by country. In China, for instance, obesity is classified as a BMI of 28 or more. Over one-third of the worldwide population is overweight, including over 10% obese, according to a thorough survey [1]. Obesity is estimated to reach 1.12 billion people worldwide by 2030 [2]. Obesity affects more than 500 million people worldwide, creating a major financial and public-health issue [3]. Obesity has sparked renewed worry and is now becoming a severe global health issue. Obesity is associated with abnormalities in triglycerides, insulin, inflammatory processes, and peroxidation, as well as a higher risk of heart disease, diabetes, and malignancy [4, 5]. According to a rising body of evidence, a bacterial imbalance in the gut contributes to obesity [6, 7]. Dietary changes, exercise, surgery, and medication are the most popular treatments for obesity. Traditional weight loss techniques, on the other hand, frequently fail to produce satisfying results, and obesity rates are expected to climb further [8]. Many dietary plants have been proven to reduce appetite, restrict food absorption, reduce adipogenesis, and increase energy consumption, and all have anti-obesity properties [9]. In the human intestinal mucosa, particularly the colon, the gut microbiota, which contains bacteria, fungi, Archea, and viruses, is common [10, 11]. The effect of gut microbiota on obesity has received a lot of attention in current history, and it might be a viable weight-loss strategy. The effects of food plants on gut flora have recently received a lot of emphasis. The gastrointestinal microbiota contains around 100 trillions of commensal bacteria, which is 10 times the body’s total density [12].

To keep its birthrates high, the gut flora feeds on nutritional remnants that people cannot process, mucous secreted either by the gut, and cells waste shed as food [13]. Short-chain fats, nutrients, and right things like a pro, analgesic, or oxidative chemicals will be produced by a healthy gut bacteria, along with potentially dangerous items such as neurotoxicity, malignancies, including immunotoxins [14, 15]. Such substances can infect humans, and immediately cause mutations, thus disrupting the defense but also physiological processes of humans. As a consequence, maintaining the body’s natural normal metabolic equilibrium need balanced intestinal bacteria. Obesity is regarded as a long net caloric consumption mismatch that results in excessive weight gain [16]. The interplay between biological and epigenetic variables, such as nourishment, dietary components, and/or lifestyle decisions, are to blame. Overall, the complex mechanisms that lead to obesity and its consequences are unknown, but recent research shows that it gastrointestinal tract the thousands of microorganisms that normally reside within the individual gastrointestinal tract should be taken into account [17]. Food absorption, energy management, and fat storage are all influenced by the intestinal microbiota and its microscopic genome, according to a new study.

Moreover, gut flora can alter the immune system of humans [18], and also the composition of bile salts, which can affect ingestion and physiology [19]. Obesity, cancer, and irritable bowel syndrome are hypothesized to be caused by gut microbial dysbiosis [20, 21]. Gram-negative bacteria lipopolysaccharide (LPS) may, for instance, produce an immune response in the recipient [22]. Obese people have a lesser variety of intestinal flora than lean people [23], and the huge quantity of specific gut microbiota taxa has changed in obese people [24]. Utilization of some food items could be negatively proportional to excess weight through modifying gut flora, according to epidemiological research [25, 26, 27]. As a consequence, eating dietary plants and taking advantage of their impact on gut microbiota management might be a novel method to treat obesity. These results indicate that gut bacteria may regulate the host’s energy metabolism, potentially leading to obesity and other disorders. This chapter’s vision is to offer a broad review of this hot issue, including the involvement of the intestinal microbiota with obesity.

Advertisement

2. Intestinal microbes

With around a hundred billion bacteria, the microorganisms in the human gastrointestinal system are large and varied. This colon is expected to have a bacterial cell density of 1011 to 1012 per ml, making it one of the world’s most densely inhabited microbial ecosystems [28]. The gut flora contains around 3 million genetic materials and hundreds of compounds, but the genome sequence only contains approximately 23,000 genes [29]. The host intestinal flora contains 10–100 trillion germs, making it challenging for biologists to characterize the whole microbiota, particularly with the classic Sanger method.

Bacteria, fungi, and viruses are among the species that make up gut bacteria. Bacteria are divided into phylums, classes, groups, families, species, and individuals. Even though only a few phyla are included, there are over 160 species [30]. The most prevalent gut microbe phyla include Species, Acidobacteria, Lactobacillus, Lactobacillus, Actinobacteria, Microbacterium, and Verrucomicrobia, alongside Taxa and Eubacterium [31]. accounting for 90% of a microbial population. The Firmicutes phylum has about 200 genera, including Escherichia, Staphylococcus, Coli, Enterobacter, and Ruminicoccus. The Clostridium genus makes up roughly 95% of the Firmicutes phylum. Bacteroidetes is a bacterial family that contains well-known bacteria which including Bacteroides and Prevotella. There are fewer bacteria in the Actinobacteria phylum, with the Bifidobacterium genus dominating [31].

The Firmicutes phylum, including comprises % of the gut bacteria, encompasses more than 200 genera, Escherichia, Pseudomonas, Vibrio, Enterobacter, and Ruminicoccus are a few examples. Almost the whole Genera class is represented by the Clostridium genus. Bacteroidetes is a bacterial family that includes well-known bacteria such as Bifidobacteria and Prevotella. The Lactobacillus genus dominates the Lactobacilli phylum, which contains a smaller amount of microbes.

2.1 Individual differences

Each section of the Gastrointestinal system has a different taxonomy and functional flora, which fluctuates throughout time as a result of perinatal changes, aging, and external conditions such as antimicrobial usage.

2.2 Anatomy of the intestine

Physiological factors such as acidity and high oxygen tension, digestion flow that is quick inside the lips but slows down afterward food supply, and finally human fluids all have an impact on the microbiota [32]. The gut provides a more difficult habitat for microbes due to its short transit times (3–5 hours) and high bile concentration. The largest microbial population is located in the large intestine, which has a slow mass flow and a normal to slightly acid pH, with obligate anaerobic bacteria dominating.

2.3 Evolution and resilience

Even though a tiny amount of pathogens via maternal blood could produce a first microbiome at delivery, fetuses are assumed to be sterile during pregnancy [33]. Viruses out from the mother and the surroundings infiltrate the newborn’s intestines almost immediately. The microbiota’s makeup is influenced by cesarean delivery, antimicrobial therapy, nutrition, and ambient hygiene [34]. Bacterial flora in your intestines is extremely stable throughout maturity, shifting just a little around a core of stable colonizers. The gut physiology and nutrition of humans alter as they get older [35]. Temporary changes, however, may occur as a result of dietary factors or antibiotic treatments. Quick medication with only a solitary prescription with antibiotic therapy, such instance, alters the intestinal flora lasting up to 4 days until returning to its previous state [36]. In addition, some bacteria might take months of rehab after treatment, resulting in a loss of diversity after multiple medication exposures [37]. Dietary modifications have a similar effect on the makeup of intestinal flora. Food provides nutrients to the host as well as the microbiota, whose bacteria may be favored or injured by dietary substrates. As a result, according to one study, changes in diet in mice could responsible for 57% of the overall point mutation in gut microbes, while gene variants accounted for only 12% [38].

So far, the gutMEGA database has collected the gut microbes of 6457 taxa [39]. Firmicutes, Bacteroides, Proteus, Actinomycetes, Fusobacteria, and Verrucomicrobia comprise the bulk of the human gut microbiota [40]. Varied gut flora is ultimately beneficial; nevertheless, a lack of choice in the gut microbiome may lead to disorders such as obesity [23]. Another feature of gut health microorganisms is a delicate balance, which refers to the gut microbiota’s capacity to resist perturbation and return to health, such as following antimicrobial therapy [41].

2.4 Changes in infant and gut bacteria makeup

The mammalian gut flora is a flexible and intricate habitat that evolved including its owner [42] which accounts for around one kg of our body weight. Our intestinal bacteria populations are rapidly being recognized as an entity with physiological, immunosuppressive, and estrogen functions that lead to illnesses [43]. Each Digestive system contains around 1014 organisms ten times the level of cells in the human body and each gut flora has 500–1000 unique types of bacteria [44, 45]. The Megahits group [25] also released a list of nearly 10 million non-redundant genes derived from decoding specimens from 1267 people, showing that the microbial community includes at least 100 times the amount of genes found in the bodily genome [46, 47, 48]. An overall current population could be classified into three groups based on the nature of the gut flora [31]. The most prevalent enterotypes are Also used Prevotella, or Rotifers, with Bacteroides, Lactobacilli, and Ruminococcus leading the pack. Although enterotype differences were previously assumed to be unrelated to region, age, race, or BMI [49], they have now been connected to long-term eating habits. The gut microbiota is a symbiotic relationship that helps the human body do things it cannot. As a result, sustaining regular GI and immunological processes, as well as proper nutrition digestion, requires the gut microbiota [12, 50]. Its microbiome, for instance, ferments metabolites indigestible food elements, synthetase enzymes, and certain other critical minerals, food poisons, and carcinogens convert cholesterol and bile salts, supports immunological reaction development, controls enterocyte growth and division, controls gastrointestinal capillaries, and protects against pathogenic strains [51]. Carbohydrate composting, its generation of short-chain fatty acids, a saturation of selected surface proteins, or the formation of minerals and abundant amino acids all seem to be the main tasks of normal gut flora [52].

2.5 Gestational age at birth

Due to organ development and external influences such as antibiotics, hospitalization, and enteral feeding, colonization is a concern in preterm neonates after birth [53, 54]. For these reasons, preterm birth might have had a considerable influence on gut and systemic immunity throughout pregnancy [54].

Preterm newborns have a limited range of bacteria, with more potentially hazardous microbes again from the Proteobacteria phylum’s Bacteria cell colonizing them [53] and decreased rates of strictly anaerobic bacteria like Bifidobacteria and lactobacilli [55], Bacteroides, and Atopobium [53]. Genetic factors, as well as the family’s secretor and Lewis blood type, impact the composition of infant formula, resulting in four phenotypes with varied amounts of oligosaccharide [56]. Premature children born to non-secretor mothers had greater Proteobacteria levels and lower Firmicutes levels [57]. Pratic et al. [58] investigated the makeup of colostrum that discovered that Health maintenance organizations linked with different mother phenotypes influence the gut microbiota of newborns. For example, health centers associated with secretor moms might provide a prebiotic benefit by lowering microorganisms linked to sepsis and necrotizing enterocolitis [57]. This suggests that health centers can alter gut flora, protecting premature babies against gut dysfunction and NEC [59]. Lactoferrin is a well-known component of human dairy that promotes the colonizing of preterm newborns’ stomachs with helpful bacteria, therefore improving their ecology [32].

2.6 Type of delivery

Babies acquire a gut that is identical to their mother’s gut microflora after normal delivery. The flora of the child’s large intestine and the related organisms of the vaginal tract, Bacteria, Lactobacilli, and Sneathia, were discovered to be closely linked in the development of biological baby mucus [60]. As per Biasucci et al. [61], significant bacteria such as Probiotic bacteria long and Lactobacillus catenulatum are familiar with the microbiome of perineal born neonates. E. coli, Staphylococcus, Bacteroides fragilis, and Bacteria are among the aerotolerant anaerobic bacteria found inside the infant gut [62, 63, 64].

In analyses done at 7 years old, variations in the microflora of C-section and perineal delivered infants were discovered [65]. Persistent autoimmune abnormalities like influenza, regional collagenous disorders, adolescent arthritis, irritable bowel [66], or overweight [67] have been linked to cesarean delivery.

2.7 Methods of milk feeding

As per research [68, 69], Equation babies are more likely to be contaminated with E. coli, Bacteroides, and Clostridium difficult than breastfeeding infants. In terms of Actinobacteria concentration, Bifidobacterium spp. has been connected to breastfeeding and artificial milk [70, 71]. In contrast to equation babies, breastfed infants have a more diverse and variable Probiotic bacteria microbiota [71]. Breastfeeding infants are provided microbiota for a more than 2 increase in Acidophilus cells as compared to supplemented infants [70]. Breastfed babies had a more favorable gut microbiota than pattern babies, with more Bifidobacterium spp. and less Clostridium difficile and Escherichia coli [23].

Maintaining a healthy and nourishing gut flora in the mother during pregnancy is also regarded to be a crucial factor in improving the milk microbiome composition. Oral supplements may increase the quantity of Acidophilus spp. and Lactobacilli spp. in human breast milk in vaginally delivered mothers [72].

2.8 Weaning period

When solid foods are introduced and dairy is eliminated, significant changes in gut flora occur. Probiotics, Escherichia coccoides, and Bifidobacteria are the most frequent species after childhood [73]. Apigenin muciniphila, Enterobacteriaceae, Veillonella, Mycobacterium coccoides spp., and Botulism spp. are all found in significant levels in the microbiota of one baby [74]. Around the age of three, the appearance and diversity of a toddler’s intestinal microbiota are most akin to those of adults [75]. Bacillus subtilis, Bacteroidetes, and Act are the three bacterial phyla that control the adult microbial population.

2.9 Antibiotics

Pharmaceuticals could alter the intestinal microbiota’s makeup to some extent. The influence of antibiotic molecular pathways on the makeup of the human microbiome was investigated in obey research [76], Penicillin treatment options alter the gut microbiota, increasing the prevalence of some species while decreasing the abundance of others. Bacterial diversity and abundance decreased during therapy. Antimicrobial class, frequency, length of therapy, pharmacokinetic properties, and target microorganisms all impact gut flora composition [77]. Antibiotic features such as antimicrobial actions and potency are important in the development of gut flora thus they are partly to blame for bacterial composition changes following antibiotic therapy [76]. The drug has unique properties and disposal methods, resulting in a wide range of bacteria material changes [77].

2.10 Gut microbiota variations between individuals

We’ve previously seen how single intestinal microbiota makeup changes, and now we’ll examine how it varies among individuals. Intertype’s, BMI levels, and extrinsic variables including behavior, health and body, race, and culinary or cultural traditions all impact cross variability.

2.11 Enterotypes

We’ve established that the gut flora composition differs across persons; now we’ll investigate how it varies between individuals. Exogenous variables including activity regularity, race, culinary and cultural habits, enterotypes, and BMI levels all play a role in these variances. Instead of an intentional integration of germs, an enterotype is a physiologically close relation between distinct species of bacteria. Although enterotypes are not as different from plasma groups in terms of structure, they are tolerant, constant through life, and may be regained if they are changed. Enterotypes appear to be mostly defined by food habits. Knowing the genesis and roles of enterotypes might help researchers better understand the links between gut flora and people’s health.

2.12 Body mass index

Many investigations [78, 79] focused on the impact of childhood obesity on intestinal flora and found that overweight or medium BMI kids had more bacterial ecology than underweight students. Intestinal flora declines with time, depending on the BMI category [78, 80]. Obese children’s microbiota has a greater Firmicutes-to-Bacteroidetes ratio than lean children’s microbiota, according to Bervoets et al. [81]. On the other hand, this obese microbiome exhibits comparably low percentages of Probiotic bacteria vulgatus and high levels of Escherichia species [81]. Adiposity is also linked to higher levels of Genus like Ruminococcaceae and decreased rates of Clostridium such as Bacteroidaceae and Enterobacter, according to Riva et al. [82]. Short-chain fatty acids were found to be higher in obese children, indicating that they used more fuel. Increased SCFA production and energy extraction from colon digestion are connected to a higher Firmicutes to Bacteroidetes ratio, indicating that intestinal flora imbalance might play a role in obesity etiology [82]. Gut flora instability is well predicted by BMI.

2.13 Ethnicity, dietary habits, and cultural habits

Although a healthy person’s microbiome is largely stable, behavior or dietary culture choices may likely alter gut microbial behavior [49]. According to a study on European children given a Western diet and Liberia children eating a diet high in grain + local vegetables with relatively low lipids and animal protein, African children’s flora contains a noticeable excess of Prevotella and Xylanibacter [83]. Shigella and E. coli bacteria are similarly underrepresented. Research [84] compared the intestinal microbiome of Hadza hunters with Italians. On either a phylum level, the Hadza gastrointestinal tract is dominated by Genus and Spirochaetes, whereas Cyanobacteria, a crucial upper octave member of the Italian gut microbiota, is almost non-existent. When the kind of food varies, biodegradation switches between carbohydrate and protein digestion. This occurred just one day after the food contacted the microorganisms in the distal intestine. Diet has a quick and long-term influence on the human microbiota, according to David et al. [85].

2.14 Exercise frequency

Bai et al. [78] discovered connections between exercise regularity and gut flora composition in a study of teenagers. Daily exercise increases gut microbial diversity by producing more SCFAs, via stimulating the production of adhesion molecules in colon epithelia, which may aid to improve gut barrier resilience, limiting mucosal leakage, and modulating cytokine secretion [78, 86].

Advertisement

3. Gut microbes in connection with obesity

The idea for studying obese people’s gut microorganisms came from the idea that gut flora might be a vital component of their long-term health. The earliest evidence of a link between gut flora and obesity was discovered in germless mouse studies. The quantity of fat and insulin sensitivity inside the transplanted increased even when food consumption was reduced, showing that gut microbes may help the recipient in the formation of adipose tissue [87]. Its Firmicutes ratio rose sharply in fat mice [88], showing that the obese mice’s microbiome was good at taking energy from the feed. Systems can be seen in individuals; for instance, in the guts of obese children, their ratio of Firmicutes climbed whereas the quantity of Bacteroidetes decreased [89]. The Firmicutes/Bacteroidetes ratio increased as BMI increased, according to a study of the Ukrainian population [90].

In overweight and obese people, supplementing with A. muciniphila improves metabolic indices [91]. Traditional probiotics like Lactobacillus and Bifidobacterium, for example, help to maintain healthy gut flora. Crovesy et al. [92] investigated the impact of Bacteria on obesity rates but found that its beneficial benefits were genus. The frequency of Lactobacillus paracasei was shown to be interrelated to fat, but the number of Escherichia repeating unit and Lactobacillus acidophilus gasseri was shown to be favorably related to obesity. Animal studies have shown that Bifidobacterium can help people lose weight. Bifidobacterium demonstrated a strain-dependent impact on obesity in diet-induced obesity animal models [93]. Obesity is linked to a reduction in Bifidobacterium abundance in the intestine [94]. The study on intestinal flora and obesity is represented in Table 1.

Obese and Microbe FeaturesPreclinical or clinicalsubjectsReferences
Firmicutes/Bacteroidetes ratio increasedPreclinicalMice[12, 24]
ClinicalChildhood[50]
ClinicalAdult Ukrainian population[51]
Increased Akkermansia population reduced body weightClinicalHuman[52]
preclinicalMice[95]
Bifidobacteria reducedPreclinicalRats[55]
Methanobacteriales smithii and Bifidobacterium were associated with normal weightClinicalHuman[96]

Table 1.

Linkage of obesity with gut microbiomes.

3.1 Obesogenic gut microbiota

Firmicutes and Bacteroidetes, for particular, have been identified as obesity-promoting intestinal flora, which can lead to the growth of obese [97].

3.2 Firmicutes and Bacteroidetes

Ruminiococcus, Candida, and Lactobacillus have been the most prevalent representatives of the phylum Firmicutes phylum Bacteroidetes in the gut bacteria, accounting for 90% of types of bacteria [44, 98]. Regulating glucagon-like peptide 1 release may aid to alleviate insulin sensitivity and obesity in way of eating obese C57BL/6 J mice given antibiotics [99]. Inside the intestines of adult C57BL/6 J rats fed a strong diet, firmicutes were found mainly [100]. In obese people and obese mice, a great proportion of Firmicutes to Bacteroidetes has just been reported as an adiposity trait of the gut microbiome [42]. Obese women having elevated toll-like receptor 5 gene expression were also shown to have a greater number of the genus [101]. Egyptian researchers examined the gut microbiome of 51 obese persons (23 kids and 28 individuals) to the gut microbiome of 28 healthy individuals in a study. In a survey of 17 children and 11 adults, researchers observed that the phyla Firmicutes and Bacteroidetes were significantly higher in the obese group (p 0.001, p = 0.003) [102]. Lactobacillus has been divided into various subgroups, each of which has been associated with obesity and the genesis of obesity. A variety of key enzymes are missing in bacteria that promote weight gain, including sugar enzymes, antioxidants, and dextrin, L-rhamnose, or acetate synthetases [103].

The three principal Bacteroidetes taxa present in the human stomach are Bacteroides, Prevotella, and Porphyromonas. Bacteroides account for more than a third of all gut bacteria, and it’s particularly prevalent in Westerners who consume a high-fat or high-sugar diet [104]. Together in a controlled trial with 138 babies aged 3 years, the utilization of Bacteroides in the intestines was found to be positively associated with bodyweight [105]. Bifidobacteria and Lactobacillus species have also been linked to weight increase in children [106, 107].

3.3 Anti-obesity gut microbiota

Certain gut microbiota species have been reported to have anti-obesity characteristics, in contrast to the obesogenic gut microbiota. In the next part, Bifid bacteria, Lactobacillus subspecies, and Bacteroidetes are investigated as anti-obesity gut microbiota.

3.4 Probiotics and obesity

C57BL/6 J mice were given Bifidobacterium lactis 420 for 12 weeks to inhibit weight gain, which may be attributed to decreased intestinal epithelial adhesion and blood LPS [108]. Probiotic lactic 420 also improved the viability and lowered the porosity of Overexpressing cells in a dose-dependent manner, suggesting that it might help with the treatment of low-grade inflammatory disorders like obesity [109]. During eight weeks, High fat-feed mice were given Bacteria bacillus bifidum BGN4 and Probiotics reticulata BORI, which significantly reduced weight gain and lowered liver triglycerides and total cholesterol, as well as blood aspartate and alanine transaminase activity [110].

Despite the reality that some Lacto strains were linked to obesity, most of the Bacillus species were found to have a pro function [98]. Lactobacillus aided fat loss in animals, whereas Bacterium gasseri aided weight loss for both obese people and animals, as per a meta-analysis [111]. Lactobacillus cultures 031 CE reduced lipid levels and the activity of aspartate transaminase and alanine transaminase in the hepatic Institute of Cancer Research mice high-fat- fat diet [110]. With down-regulating- regulating TNF-, interleukin-1, and Nuclear factor and upregulating IL-10 and tight junction, Bacteria sakei OK67 treatment to fat-fed mice greatly lower body or epididymides fat excess weight [112]. Par-, PR domain containing 16, Par- coactivator-1, growth factor protein 7, and fibroblast growth factor 21, were all increased by Bacteria consisting of a resistor 263 in Adult male rats [113].

Advertisement

4. Obesity mechanism induced by gut micro-biota

4.1 Energy absorption

To provide energy to their humans, obese rats consume more carbohydrates via their gut bacteria [114, 115]. When bacteria mice colonized predominantly by the obesity microbiota’ did not change their food or weight, their total body fat increased in comparison to mice colonized by the Chilean biome’ [88]. Obese people’s gut microbiota has a larger capacity for absorbing energy from meals, according to the study. Obese mice had higher lipid uptake, according to a multi-omics study. In germ-free mice, Clostridia colonization downregulates genetic variants’ fat intake [47]. In a way, the gut bacteria of fat people may produce more impact energy, leading to higher energy and weight growth. Difficult-to-digest carbohydrates are fermented by gut bacteria into short-chain fatty acids, which are either eaten or expelled in the stool. Short-chain fatty acids are necessary to maintain energy balance [116]. SCFAs have lately received a lot of attention for their positive effects on cellular integrity and lipid metabolism, although their relevance in obesity is still debatable. Intestinal permeability, metabolic disease indicators, obesity, and hypertension have all been associated with increased fecal SCFA levels [117].

4.2 Central appetite and fat accumulation

The gut microbiota has become one of the most transcription factors of intestine connection. Within the study of the morphological and molecular origins of obesity and associated illnesses, the gastrointestinal system pathway has attracted much interest. Hormonal, immunological, or neurological pathways connect both brains with the microbiome [118]. The intestinal microbiota link influences the nerve cells of said individual. The autonomic nervous system can affect the makeup and structure of the gut flora. Microbiomes affect cognitive activity in a variety of ways, including by influencing the synthesis of neuropeptides like dopamine, which are critical for gastrointestinal function regulation [119]. Lactate, a nerve terminal fuel generated by Lactobacillus and Bifidobacterium, has now been demonstrated to enhance satisfaction following a meal [120]. Protracted hunger suppression controlled via hypothalamic neurotransmitter energetic pathways can be paired with short-term stomach pleasure regulation linked with bacterial proliferation [121]. Table 2 depicts the obesity process as part of gut flora.

InfluenceFeatures of MicrobesProcessReferences
Load capacity has increased.Streptomyces depletion with Sulfolobus proliferationThe expression in genes that govern lipid absorption, such as CD36, has increased.[122]
The host will have more energy.Fusobacterium, Roseburia feces, and other Cycle life grew in number, whereas Akkermansia muciniphila, Alistipes finegoldii, Bacteroides, Christensenellaceae, Methanobrevibacter, and Oscillospira dropped in the count.Short-chain fatty acids in abundance[117]
Hunger riseClostridial clusters XIVa and IV prevail in this colony.Neuropeptide levels were significantly lower in obese subjects.[123, 124, 125]
Fat accumulation has increased.Gut bacteria from normally grown mice were transferred into microbe mice.Increased synthesis of Articulate and Depositors, which activates LPL and helps triglyceride entry into the bloodstream out from the liver, suppresses Fiaf.[87]

Table 2.

Adiposity caused by gut microbes.

In 2004, it was shown that gut microbes can influence fat accumulation [87]. The gut bacteria upregulates two key signaling pathways, glycemic reaction component binding domain or cholesterol control component related proteins, causing fat to accumulate in hepatic. Lipids directly stimulate through the liver, where they can be absorbed via visceral fat, thanks to lipoprotein lipase. Fiaf, an LPL regulator, is produced by intestinal epithelial cells. Normal mouse intestinal epithelial cells have Fiaf inhibited, allowing the host to store more energy.

Advertisement

5. Obesity and microbiota: Connectivity to genetic makeup and transport

A combination of genetic and chemical variables impacts obesity. The microbe is thought to be influenced by inheritance. In actuality, several gene mutations might be responsible for changes in the structure but also diversity of the intestinal microbiota in obese people. A connection between twin genetic variation and distinct microbial species was discovered using whole-genome correlation. More than a dozen gut microbes have been linked to good health [126]. Genes affect bacteria, as evidenced by Probiotic bacteria and the lactose intolerance genome cluster [126] and AMY1-CN as candidate genes linked to the shape and severity of the microbial [127]. It’s also possible that the gut microbiota is handed down from mother to kid. The gastrointestinal tract of spore mice was shown to be relatively stable in succession studies. In most cases, these bacteria make up a great proportion of the gut flora of mice, suggesting that rodents get the majority of their intestinal flora from their mothers [128]. The microbial community may be detected in the womb, synovial fluid, amniotic fluid, and even mucus, according to the study, so parental microbes could have a major impact on the development of the child’s microflora [129]. Obesity is caused by a variety of causes, one of which is a bad diet. In industrialized nations and places, the consumption of high-fat and high-sugar meals has steadily increased, increasing obesity. Changes in nutrition have a profound impact on intestinal flora since gut bacteria rely on human food for survival and energy. Bacteroidetes were detected in reduced quantities in rats given a strong diet, although Firmicutes or Proteobacteria were found in higher levels. Similar changes were observed in mice who were not overweight, implying as saturated cholesterol would have a detrimental influence on this microbiota [130, 131]. The gut microbiota can be dysbiotic due to both hereditary and environmental causes. Figure 1 shows that dysregulation could indeed affect energy uptake through transcriptional but also heavily rely on short-chain lipids, and also enhance core hunger via the intestine pivot, intestines estrogen, or neuropeptides; restrict fat metabolism via signaling pathways and glycoprotein lysozyme; trigger serious swelling via immunomodulation cell proliferation but also lipoteichoic acid, and obstruct the sleep cycle by influencing. Obesity vulnerability tends to be enhanced by these variables.

Figure 1.

Obesity emerges as a result of the microbiota’s dysregulation, which is produced by the microbiota’s immediate touch with local cells.

Sleep deprivation can also contribute to obesity. Sleep deprivation can impact intestinal flora and thus cause weight gain by interrupting sleep cycles. Insomnia led to huge dietary intake and long-term alterations within gut flora, with Lactobacillaceae and Ruminococcus content levels increasing and Lactobacillaceae abundance values dropping. These factors promote peripheral and visceral white adipose tissue irritation, and glycemic control changes [132]. Stress stimulates desire that leads to overweight by the application that regulates metabolism thus promoting the ingestion of desserts and fats meals [133].

5.1 Eating flora pro impact via modifying gut flora

Fruits, veggies, peppers, cereals, grain, and tea are just a few of the foods that were demonstrated to reduce obesity through modulating the microbiota and activity in the intestine [9, 134, 135].

5.2 Fruits

Fruit is rich in phenolics, pectin, and xylose, which may help prevent obesity, cancer, and heart disease [136, 137]. A 122-person randomized trial in the United Kingdom discovered that increasing fruit and vegetable consumption altered the aspects of the human intestinal flora, with an increase through Clostridium providing a broad range of bromine and a decrease in pathogens Clostridia, which could be linked to obesity prevention [138].

As shown in Figure 2, taking pro supplements Organic vegetables in the diet boosts pro gut flora while reducing obesity-promoting bacteria. Toxins produced by a gastrointestinal microbiota with amplitude modulation may help with weight loss by lowering ghrelin, reducing fat storage by bottom triglycerides and up-regulating adipocytes charring, enhancing gastric mucosal feature, but also reducing intestine soreness by lowering Tumor necrosis factor, Nuclear factor, or Lipid polysaccharides, and improving gut mucosal function.

Figure 2.

Mechanisms of dietary plant weight reduction benefits through gut bacteria modifications.

5.3 Grapes

Grapes are a nutrient-dense fruit that is abundant in resveratrol, a natural flavonoid with a slew of health advantages [136, 137]. In HFD-fed rats, resveratrol reduced weight growth and subcutaneous adipose weight while boosting the Bacteroidetes to Genera ratios, Streptococcus, and Probiotics while decreasing E. coli faecalis. The anti-obesity effects of resveratrol may be due to lower gene expression of medical field enzymes such as lipolysis, acylated deaminase 1, propyl hydroxylase 1, or fatty acid synthase [134]. In contrast, feeding C57BL/6 J mice grape pomace and cinnamon bark extract for 8 weeks lowered obesity by lowering fat mass, adipose irritation, and modifying gut microbiota and intestinal barrier indicators. Allobaculum and Rose bury were up-regulated in C57BL/6 J mice following treatment with combined extracts, Enzyme activities, and Lactobacillus, on the other hand, were away back [139].

5.4 Apples

Firmicutes, Bifidobacteria, E. coli, Enterobacter, Vibrio cholera, but also Probiotics were brewed with fecal matter from nutrition obese mice, and the crude extract was able to control the gut flora of organisms linked to obesity by altering the volumes of Genus, Bifidobacteria, Enterobacter, E.coli, Escherichia coli Moreover, 0.5% polymerization semi fruit fulfillment reduced budget deficit obesity in rats fed a high-fat by lowering the Genera to Bacteroidetes ratios while eightfold doubling the levels of Akkermansia [140].

5.5 Berries

Many currants, such as blueberries, black currants, and plant-feeding-feeding- feeding, have been known as the anti properties by affect the gut flora [141, 142, 143]. By lowering Tumor necrosis factor or interleukin levels, enhancing insulin production, and raising Gammaproteobacteria density in Wistar rats, blueberries powdered may protect them against High fat-induced inflammation [144].

Pro bacteria like Akkermansia and Desulfovibrio can also be increased and whole black raspberries may lower intestinal inflammation [145]. Proanthocyanidins, a polyphenols duo prevalent in strawberries, were given to adult Zealand white bunnies for twelve weeks to alleviate nutrition adiposity by raising the quantity of Bifidobacteria at the phylum level and Akkermansia at the genera [146].

5.6 Other fruits

In diabetic mice on the High - fat diet, mangoes with 10% restored the frequency of Bifidobacteria and Akkermansia, lowering intestinal microbiota coccidiosis [147]. Poly methoxy flavones and hydroxyl poly ethoxy flavones, both found in citrus peels, have been shown to reduce body mass and adipocytes bulk in high-fat-fed mice by lowering oil droplets, perilipin 1 nutrients, and glycosides controlling signal sequence 1, as well as raising Prevotella and reducing rc4–4 microbes within rat digestive tract [148].

5.7 Vegetables

In terms of attributes, a chloroplast component found in all green vegetable tissue has been shown to enhance weight reduction in rats by boosting Bacteroides fragilis while boosting hunger [149]. In cross-sectional research with healthy females, increasing soluble fiber intake from veggies and fruits was proven to reduce tall weight gain and increase Ruminococcaceae abundance, and improved respiration [26].

5.8 Legumes

In nutrition obese mice, pea flour had a considerable anti-obesity impact and enhanced the Bacteroidetes to Firmicutes ratio [150]. Soy proteins are known to reduce rat fat mass or fat percentage by 10%, enhance hepatotoxicity and tertiary bile acids, and enhance Lactobacillus prevalence while reducing Blautia, and Lachnospiraceae richness [151]. Likewise, mung bean proteins, that are high in 8-globulin, are said to reduce adiposity formation and excess weight caused by the HFD, as well as ketoacidosis [152]. Mung bean proteins, on the other hand, were linked to an increase in Bifidobacteria and just a decline in Genus, a raise in intestine glucosidase potential associated tiers, and a higher primary biliary total acidity.

5.9 Tea

Tea has been a popular beverage for a long time. Tea has recently shown anti-obesity capabilities through a variety of means, including lowering fat accumulation in cells and changing gut microbiota [153]. However, dosing of C57BL/6 J mice with crude extract of green, oolong, and black tea indicated that these tea extracts improved glycemic control and also decreased weight gain through modifying the gut microbiota. The Rikenellaceae and Desulfovibrionaceae families were decreased in number, leading to greater SCFA levels, lower lipopolysaccharide tiers, and improved glucose metabolism [154]. By enhancing the percentages of Genus to Bifidobacteria and Bifidobacteria to Lactobacilli, and also flattening the looks of lipid metabolism and offensive genetic makeup in white adipose tissue, kefir black tea effectively reduced weight gain but also abdominal obesity in obese rats without any influence on caloric intake [155].

5.10 Spices, turmeric and chili

Herbs have such a longstanding experience of usage in food flavoring, while polyphenol found in spices has been demonstrated to get a variety of bioactivity, Anti-obesity, anti-cancer, anti-inflammatory, and anti-bacterial growth suppression are only a few of the benefits [156, 157]. Turmeric contains curcumin, which is a key bioactive component with a lengthy range of health benefits. Turmeric has been demonstrated to have a significant effect on the public of certain intestinal microbiota in mice, notably Lactobacilli, Bacteroidaceae, and Rikenella, which have both been linked to obesity-related illnesses [135]. Curcumin decreased weight gain in obese menopausal rats without affecting estrogen levels and improved gut microbiota diversity [158].

Because capsaicin is a key component of chili’s bioactive components, it’s one of the most popular hot flavors. According to studies [159], capsaicin reduced weight gain and inactivated the muscarinic receptor type 1 in rats on the High - fat diet. Capsaicin reduced microorganisms and increased Aeruginosa muciniphila in high-fat-fed mice [160].

5.11 Obesity and short-chain fatty acids

The most prevalent compounds in gut flora are sterols, which have some important pharmacological roles in keeping the host alive. By functioning as a link between the intestinal microbiota and the host, these chemicals influence barrier function, irritation regulation, bile salt conversion, immunological activity, and infection control. Despite their modest levels in the vascular, acetate and benzoate have direct impacts on organs by activating the hormonal and neurologic systems. For example, pectin is both a fossil fuel for epithelium and a histone deacetylase inhibitor that affects gene expression and cell destiny [161]. In adults, phytic acid suppresses fatty acid synthesis while simultaneously acting as a moderate pro in the gut [162]. Likewise, the microbiota’s citric acid serves a variety of physiologic purposes. It is a precursor for lipid production [163], and an appetite suppressant via a primary hypothalamus pathway [164].

Short-chain fatty acids, primarily butyric acid, provide around 70% of fuel to the epithelium [165]. Acetic, propionic, and butyric acids can thus operate as both anabolic nutrients and chemical messengers in a wide range of cell activities [34].

Indigestible carbohydrate fibfibersres provide an extra biochemical energy source for the gut flora. Sulfonamides, the major metabolic byproducts, can be used for Vivo lipid or glycogen production [12]. The change in Short-chain- chain fatty acids levels in obese could be attributed to intestinal bacteria in the gut microbiome. This complex microbial population has a higher metabolic ability and performs a variety of tasks in the human gut [87].

The gut bacteria aid in the breakdown of raw carbohydrates into readily digestible oligosaccharides, as well as villus epithelial triglyceride lipase activity and Short-chain fatty acids synthesis [166], both of which are important for the host’s nutrition and energy management. Intestinal bacteria may contribute to obesity by increasing nutrition and altering host lipid metabolic activity, as well as fueling homeostasis through its metabolites [167]. It’s not unexpected that changes in intestinal flora diversity, with Firmicutes being more numerous in obese than lean patients, cause problems with energy uptake and management [28]. In the Netherlands, obese and overweight people exhibited higher fecal matter Short-chain- chain fatty acids concentrations and more Genera than their slim equivalents, according to research. Obese people are expected to yield more colon SCFA, implying a higher microbial power harvest [168, 169], confirming the theory that changes in SCFA levels in obesity are caused by dysregulation in the colon microbiome. Even more clearly, the gut flora influences weight control via SCFAs, altering energy imbalance and DNA synthesis through miRNAs [79].

Advertisement

6. Conclusion

Every person’s gut microbiota is unique to them. In the formative years (4–36 months), intestine maturity shapes fundamental native flora, which is influenced by that does, birth gestation age, type of delivery, milky nursing techniques, weaning duration, lifestyle, and dietary and sociocultural practices. The gut microbiota, which plays a vital role in individual energy balance, is connected to obesity. Because some gut microorganisms associated with Lactobacillus, Genera, and Bifidobacteria are linked to weight increase, whereas Bifidobacterium, most Lactobacillus, and some Bifidobacteria have anti-obesity functions, the effects of intestinal microbiota on obesity development are species-dependent. Obesity is linked to a dysregulation of gut flora. Obesity has indeed been connected to a variety of bacteria in the intestine. They raise the recipient’s elastic modulus, and hypothalamic desire, including fat deposition, promoting the start and progression of obesity. Because of the diversity and variety of gut microbes, the strategy whereby it induces obesity needs to be researched further. Adiposity is the outcome of the interaction of genetic and environmental factors. A range of dietary items, including fruits (grapes, apples, and berries), vegetables, spices, legumes, cereals, and tea, have been demonstrated to modify the composition in some recent experimental and epidemiological investigations. Obese and overweight persons have greater amounts of Short-chain-chain fatty acids and more Genera in their feces than slender ones. Future research will concentrate on research methodology using survey strategy to best investigate the function of the intestinal flora link, substitute research of conservation concerns to spot possible microbial delegates of gut bacteria related to diet, and specific microbiomes regulation for obese people.

Advertisement

Acknowledgments

We thank the digital library GCUF for providing access to the publication.

Advertisement

Conflict of interest

There is no conflict of interest as declared by all authors.

References

  1. 1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. The New England Journal of Medicine. 2017;377:13-27 [PMID: 28604169. DOI: 10.1056/NEJMoa1614362
  2. 2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity. 2008;32:1431-1437 [PMID: 18607383. DOI: 10.1038/ijo.2008.102
  3. 3. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: Shaped by global drivers and local environments. Lancet. 2011;378(9793):804-814. DOI: 10.1016/S0140-6736(11)60813-1
  4. 4. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. The Journal of Clinical Investigation. 2017;127:1-4 [PMID: 28045402. DOI: 10.1172/JCI92035
  5. 5. Bendor CD, Bardugo A, Pinhas-Hamiel O, Afek A, Twig G. Cardiovascular morbidity, diabetes, and cancer risk among children and adolescents with severe obesity. Cardiovascular Diabetology. 2020;19:79 [PMID: 32534575. DOI: 10.1186/s12933-020-01052-1
  6. 6. Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535:56-64 [PMID: 27383980. DOI: 10.1038/nature18846
  7. 7. Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018;9:308-325 [PMID: 29667480. DOI: 10.1080/19490976.2018.1465157
  8. 8. Kazemipoor M, Cordell GA, Sarker MMR, Radzi CWJBWM, Hajifaraji M, Kiat PE. Alternative treatments for weight loss: Safety/risks and effectiveness of anti-obesity medicinal plants. International Journal of Food Properties. 2015;18(9):1942-1963
  9. 9. Fu CH, Jiang Y, Guo J, Su ZQ. Natural products with anti-obesity effects and different mechanisms of action. Journal of Agricultural and Food Chemistry. 2016;64:9571-9585
  10. 10. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature. 2010;464:59e65
  11. 11. Lopez-Legarrea P, Fuller NR, Zulet MA, Martinez JA, Caterson ID. The influence of Mediterranean, carbohydrate, and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pacific Journal of Clinical Nutrition. 2014;23:360e8
  12. 12. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915-1920 [PMID: 15790844. DOI: 10.1126/science.1104816
  13. 13. Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776-780 [PMID: 30442802. DOI: 10.1126/science.aau5812
  14. 14. Miyamoto J, Igarashi M, Watanabe K, Karaki SI, Mukouyama H, Kishino S, et al. Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids. Nature Communications. 2019;10:4007 [PMID: 31488836. DOI: 10.1038/s41467-019-11978-0
  15. 15. Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD, and T2DM. Nature Reviews. Endocrinology. 2019;15:261-273 [PMID: 30670819. DOI: 10.1038/s41574-019-0156-z
  16. 16. Hill JO. Understanding and addressing the epidemic of obesity: An energy balance perspective. Endocrine Reviews. 2006;27(7):750-761
  17. 17. Clavel T, Desmarchelier C, Haller D, Gerard P, Rohn S, Lepage P, et al. Intestinal microbiota in metabolic diseases: From bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes. 2014;5(4):544-551. DOI: 10.4161/gmic.29331
  18. 18. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology. 2009;9:313-323
  19. 19. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-β-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism. 2013;17:225-235
  20. 20. Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nature Medicine. 2018;24(4):392-400
  21. 21. Postler TS, Ghosh S. Understanding the holobiont: How microbial metabolites affect human health and shape the immune system. Cell Metabolism. 2017;26(1):110-130
  22. 22. Shen J, Obin MS, Zhao L. The gut microbiota, obesity, and insulin resistance. Molecular Aspects of Medicine. 2013;34:39-58
  23. 23. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484
  24. 24. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:11070-11075
  25. 25. Kang C, Zhang Y, Zhu XH, Liu K, Wang XL, Chen MT, et al. Healthy subjects differentially respond to dietary capsaicin correlating with specific gut enterotypes. Journal of Clinical Endocrinology & Metabolism. 2016;101(12):4681-4689
  26. 26. Menni C, Jackson MA, Pallister T, Steves CJ, Spector TD, Valdes AM. Gut microbiome diversity and high fiber intake are related to lower long-term weight gain. International Journal of Obesity. 2017;41(7):1099-1105
  27. 27. Moreno-Indias I, Sánchez-Alcoholado L, Pérez-Martinez P, Andrés-Lacueva C, Cardona F, Tinahones F, et al. Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients. Food & Function. 2016;7(4):1775-1787
  28. 28. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022-1023
  29. 29. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:36-44
  30. 30. Laterza L, Rizzatti G, Gaetani E, Chiusolo P, Gasbarrini A. The gut microbiota and immune system relationship in human graft-versus-host disease. Mediterranean Journal of Hematology Infections Diseases. 2016;8:e2016025
  31. 31. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174-180
  32. 32. Mastromarino P, Capobianco D, Campagna G, Laforgia N, Drimaco P, Dileone A, et al. Correlation between lactoferrin and beneficial microbiota in breast milk and infant’s feces. Biometals. 2014;27:1077-1086
  33. 33. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Science Translational Medicine. 2014;6(237):237ra265. DOI: 10.1126/scitranslmed.3008599
  34. 34. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biology. 2007;5(7):e177
  35. 35. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439. DOI: 10.1126/science.1237439
  36. 36. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biology. 2008;6(11):e280. DOI: 10.1371/journal.pbio.0060280
  37. 37. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proceedings National Academic Science USA. 2011;108(Suppl 1):4554-4561. DOI: 10.1073/pnas.1000087107
  38. 38. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between gut microbiota, host genetics and diet relevant to the development of metabolic syndromes in mice. The ISME Journal. 2010;4(2):232-241. DOI: 10.1038/ismej.2009.112
  39. 39. Zhang Q, Yu K, Li S, et al. gutMEGA: A database of the human gut MEtaGenome Atlas. Briefings in Bioinformatics. May 2021;22(3):bbaa082. DOI: 10.1093/bib/bbaa082. PMID: 32496513
  40. 40. Consortium HMP. Structure, function, and diversity of the healthy human microbiome. Nature. 2012;486:207-214 [PMID: 22699609. DOI: 10.1038/nature11234
  41. 41. Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, et al. Defining a healthy human gut microbiome: Current concepts, future directions, and clinical applications. Cell Host & Microbe. 2012;12:611-622 [PMID: 23159051. DOI: 10.1016/j.chom.2012.10.012
  42. 42. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, et al. Evolution of mammals and their gut microbes. Science. 2008;320(5883):1647-1651
  43. 43. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Reports. 2006;7(7):688-693. DOI: 10.1038/sj.embor.7400731
  44. 44. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635-1638
  45. 45. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355-1359
  46. 46. Li J, Jia H, Cai X, Zhong H, Feng Q , Sunagawa S, et al. An integrated catalog of reference genes in the human gut microbiome. Nature Biotechnology. 2014;32(8):834-841. DOI: 10.1038/nbt.2942
  47. 47. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449(7164):811-818
  48. 48. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65
  49. 49. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-108. DOI: 10.1126/science.1208344
  50. 50. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annual Review of Nutrition. 2002;22:283-307
  51. 51. Gerard P, Bernalier-Donadille A. Les fonctions majeures du microbiote intestinal. Cahiers de Nutrition et de Die’te’tique. 2007;42:S28-S36
  52. 52. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Medicine. 2016;8:51 [PMID: 27122046. DOI: 10.1186/s13073-016-0307-y
  53. 53. Arboleya S, Binetti A, Salazar N, Fernández N, Solís G, Hernández-Barranco A, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiology Ecology. 2012;79:763-772
  54. 54. Ren S, Hui Y, Obelitz-Ryom K, Brandt AB, Kot W, Nielsen DS, et al. Neonatal gut and immune maturation is determined more by postnatal age than by post-conceptional age in moderately preterm pigs. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2018;315:G855-G867
  55. 55. Butel MJ, Suau A, Campeotto F, Magne F, Aires J, Ferraris L, et al. Conditions of bifidobacterial colonization in preterm infants: A prospective analysis. Journal of Pediatric Gastroenterology and Nutrition. 2007;44:577-582
  56. 56. Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, Peila C, et al. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011;128:e1520-e1531
  57. 57. Underwood MA, Gaerlan S, De Leoz ML, Dimapasoc L, Kalanetra KM, Lemay DG, et al. Human milk oligosaccharides in premature infants: Absorption, excretion, and influence on the intestinal microbiota. Pediatric Research. 2015;78:670-677
  58. 58. Praticò G, Capuani G, Tomassini A, Baldassarre ME, Delfini M, Miccheli A. Exploring human breast milk composition by NMR-based metabolomics. Natural Product Research. 2014;28:95-101
  59. 59. Bering SB. Human milk oligosaccharides to prevent gut dysfunction and necrotizing enterocolitis in preterm neonates. Nutrients. 2018;10:1461
  60. 60. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings National Academic Science USA. 2010;107:11971-11975
  61. 61. Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. The Journal of Nutrition. 2008;138:1796S-1800S
  62. 62. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: Mom matters. Trends in Molecular Medicine. 2015;21:109-117
  63. 63. Pantoja-Feliciano IG, Clemente JC, Costello EK, Perez ME, Blaser MJ, Knight R, et al. Biphasic assembly of the murine intestinal microbiota during early development. The ISME Journal. 2013;7:1112-1115
  64. 64. Grönlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after cesarean delivery. Journal of Pediatric Gastroenterology and Nutrition. 1999;28:19-25
  65. 65. Salminen S, Gibson GR, McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut. 2004;53:1388-1389
  66. 66. Sevelsted A, Stokholm J, Bønnelykke K, Bisgaard H. Cesarean section and chronic immune disorders. Pediatrics. 2015;135:e92-e98
  67. 67. Chen G, Chiang WL, Shu BC, Guo YL, Chiou ST, Chiang TL. Associations of caesarean delivery and the occurrence of neurodevelopmental disorders, asthma or obesity in childhood based on Taiwan birth cohort study. BMJ Open. 2017;7:e017086
  68. 68. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. Gut microbiota of healthy Canadian infants: Profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013;185:385-394
  69. 69. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511-521
  70. 70. Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe. 2011;17:478-482
  71. 71. Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology. 2010;156:3329-3341
  72. 72. Mastromarino P, Capobianco D, Miccheli A, Praticò G, Campagna G, Laforgia N, et al. Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery. Pharmacological Research. 2015;95:63-70
  73. 73. Fallani M, Amarri S, Uusijarvi A, Adam R, Khanna S, Aguilera M, et al. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology. 2011;157:1385-1392
  74. 74. Tidjani Alou M, Lagier JC, Raoult D. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Human Microbiome Journal. 2016;1:3-11
  75. 75. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222-227
  76. 76. Pérez-Cobas AE, Artacho A, Knecht H, Ferrús ML, Friedrichs A, Ott SJ, et al. Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One. 2013;8:e80201
  77. 77. Iizumi T, Battaglia T, Ruiz V, Perez GI. Gut microbiome and antibiotics. Archives of Medical Research. 2017;48:727-734
  78. 78. Bai J, Hu Y, Bruner DW. Composition of Gut Microbiota and its Association with Body Mass Index and Lifestyle Factors in a Cohort of 7-18 Years Old Children from the American Gut Project. Obes: Pediatr; 2018
  79. 79. Karlsson CL, Onnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity. 2012;20:2257-2261
  80. 80. Yun Y, Kim HN, Kim SE, Heo SG, Chang Y, Ryu S, et al. Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort. BMC Microbiology. 2017;17:151
  81. 81. Bervoets L, Van Hoorenbeeck K, Kortleven I, Van Noten C, Hens N, Vael C, et al. Differences in gut microbiota composition between obese and lean children: A cross-sectional study. Gut Pathogens. 2013;5:10
  82. 82. Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, et al. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations. Environmental Microbiology. 2017;19:95-105
  83. 83. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceeding of National Academic Science USA. 2010;107:14691-14696
  84. 84. Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, et al. Gut microbiome of the Hadza hunter-gatherers. Nature Communications. 2014;5:3654
  85. 85. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559-563
  86. 86. Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, et al. Exercise modifies the gut microbiota with positive health effects. Oxidative Medicine and Cellular Longevity. 2017;3831972
  87. 87. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proceeding of National Academic Science USA. 2004;101:15718-15723 [PMID: 15505215. DOI: 10.1073/pnas.0407076101
  88. 88. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031 [PMID: 17183312. DOI: 10.1038/nature05414
  89. 89. Indiani CMDSP, Rizzardi KF, Castelo PM, Ferraz LFC, Darrieux M, Parisotto TM. Childhood obesity and Firmicutes/Bacteroidetes ratio in the gut microbiota: A systematic review. Childhood Obesity. 2018;14:501-509 [PMID: 30183336. DOI: 10.1089/chi.2018.0040
  90. 90. Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiology. 2017;17:120 [PMID: 28532414. DOI: 10.1186/s12866-017-1027-1
  91. 91. Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proofof-concept exploratory study. Nature Medicine. 2019;25:1096-1103 [PMID: 31263284. DOI: 10.1038/s41591-019-0495-2
  92. 92. Crovesy L, Ostrowski M, Ferreira DMTP, Rosado EL, Soares-Mota M. Effect of lactobacillus on body weight and body fat in overweight subjects: A systematic review of randomized controlled clinical trials. International Journal of Obesity. 2017;41:1607-1614 [PMID: 28792488. DOI: 10.1038/ijo.2017.161
  93. 93. Yin YN, Yu QF, Fu N, Liu XW, Lu FG. Effects of four Bifidobacteria on obesity in high-fat diet-induced rats. World Journal of Gastroenterology. 2010;16:3394-3401 [PMID: 20632441. DOI: 10.3748/wjg.v16.i27.3394
  94. 94. Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, Tuohy KM, et al. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. Journal of Proteome Research. 2009;8:2361-2375 [PMID: 19275195. DOI: 10.1021/pr8009885
  95. 95. Anhê FF, Roy D, Pilon G, Dudonné S, Matamoros S, Varin TV, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64:872-883 [PMID: 25080446. DOI: 10.1136/gutjnl-2014-307142
  96. 96. Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, et al. Obesity-associated gut microbiota is enriched in lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of Obesity. 2012;36:817-825 [PMID: 21829158. DOI: 10.1038/ijo.2011.153
  97. 97. Prior RL, Wilkes S, Rogers T, Khanal RC, Wu X, Hager TJ, et al. Dietary black raspberry anthocyanins do not alter the development of obesity in mice fed an obesogenic high-fat diet. Journal of Agricultural and Food Chemistry. 2010;58:3977-3983
  98. 98. Barlow GM, Yu A, Mathur R. Role of the gut microbiome in obesity and diabetes mellitus. Nutrition in Clinical Practice. 2015;30:787-797
  99. 99. Hwang I, Park YJ, Kim YR, Kim YN, Ka S, Lee HY, et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. Federation of American Societies for Experimental Biology Journal. 2015;29(6):2397-2411
  100. 100. Shang Y, Khafipour E, Derakhshani H, Sarna LK, Woo CW, Siow YL, et al. A short-term high-fat diet induces obesity-enhancing changes in mouse gut microbiota that are partially reversed by cessation of the high-fat diet. Lipids. 2017;52(6):499-511
  101. 101. Pekkala S, Munukka E, Kong L, Pollanen E, Autio R, Roos C, et al. Toll-like receptor 5 in obesity: The role of gut microbiota and adipose tissue inflammation. Obesity. 2015;23(3):581-590
  102. 102. Ismail NA, Ragab SH, Abd ElBaky A, Shoeib ARS, Alhosary Y, Fekry D. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Archives of Medical Science. 2011;7(3):501-507
  103. 103. Drissi F, Merhej V, Angelakis E, El Kaoutari A, Carrière F, Henrissat B, et al. Comparative genomics analysis of lactobacillus species associated with weight gain or weight protection. Nutrition & Diabetes. 2014;4:e109
  104. 104. Johnson EL, Heaver SL, Walters WA, Ley RE. Microbiome and metabolic disease: Revisiting the bacterial phylum Bacteroidetes. Journal of Molecular Medicine. 2017;95(1):1-8
  105. 105. Vael C, Verhulst SL, Nelen V, Goossens H, Desager KN. Intestinal microflora and body mass index during the first three years of life: An observational study. Gut Pathogens. 2011;3:8
  106. 106. Koleva PT, Bridgman SL, Kozyrskyj AL. The infant gut microbiome: Evidence for obesity risk and dietary intervention. Nutrients. 2015;7(4):2237-2260
  107. 107. Kolida S, Gibson GR. Synbiotics in health and disease. Annual Review of Food Science and Technology. 2011;2:373-393
  108. 108. Stenman LK, Waget A, Garret C, Klopp P, Burcelin R, Lahtinen S. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Beneficial Microbes. 2014;5(4):437-445
  109. 109. Mokkala K, Laitinen K, Röytiö H. Bifidobacterium lactis 420 and fish oil enhance intestinal epithelial integrity in Caco-2 cells. Nutrition Research. 2016;36(3):246-252
  110. 110. Li Z, Jin H, Oh SY, Ji GE. Anti-obese effects of two lactobacilli and two Bifidobacteria on ICR mice fed on a high-fat diet. Biochemical and Biophysical Research Communications. 2016;480(2):222-227
  111. 111. Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of lactobacillus species on weight gain in humans and animals. Microbial Pathogenesis. 2012;53(2):100-108
  112. 112. Lim SM, Jeong JJ, Woo KH, Han MJ, Kim DH. Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutrition Research. 2016;36(4):337-348
  113. 113. Chen LH, Chen YH, Cheng KC, Chien TY, Chan CH, Tsao SP, et al. Antiobesity effect of lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in high-energy-diet-fed rats. Journal of Nutritional Biochemistry. 2018;54:87-94
  114. 114. Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutrition in Clinical Practice. 2012;27:201-214 [PMID: 22367888. DOI: 10.1177/0884533611436116
  115. 115. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World Journal of Gastroenterology. 2014;20:16079-16094 [PMID: 25473159. DOI: 10.3748/wjg.v20.i43.16079
  116. 116. Cani PD, Van Hul M, Lefort C, Depommier C, Rastelli M, Everard A. Microbial regulation of organismal energy homeostasis. Nature Metabolism. 2019;1:34-46 [PMID: 32694818. DOI: 10.1038/s42255-018-0017-4
  117. 117. de la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, Velásquez-Mejía EP, Sierra JA, Corrales Agudelo V, et al. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients. 2018;11 [PMID: 30591685. DOI: 10.3390/nu11010051
  118. 118. Cryan JF, O'Riordan KJ, CSM C, Sandhu KV, TFS B, Boehme M, et al. The microbiota-gut-brain axis. Physiological Reviews. 2019;99:1877-2013 [PMID: 31460832. DOI: 10.1152/physrev.00018.2018
  119. 119. Shajib MS, Khan WI. The role of serotonin and its receptors in the activation of immune responses and inflammation. Acta Physiologica (Oxford, England). 2015;213:561-574 [PMID: 25439045. DOI: 10.1111/apha.12430
  120. 120. Silberbauer CJ, Surina-Baumgartner DM, Arnold M, Langhans W. Prandial lactate infusion inhibits spontaneous feeding in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2000;278:R646-R653 [PMID: 10712284. DOI: 10.1152/ajpregu.2000.278.3.R646
  121. 121. Fetissov SO. Role of the gut microbiota in host appetite control: Bacterial growth to animal feeding behavior. Nature Reviews. Endocrinology. 2017;13:11-25 [PMID: 27616451. DOI: 10.1038/nrendo.2016.150
  122. 122. Petersen C, Bell R, Klag KA, Lee SH, Soto R, Ghazaryan A, et al. T cell-mediated regulation of the microbiota protects against obesity. Science. 2019;365 [PMID: 31346040. DOI: 10.1126/science.aat9351
  123. 123. Wu Y, He H, Cheng Z, Bai Y, Ma X. The role of neuropeptide Y and peptide YY in the development of obesity via the gut-brain axis. Current Protein & Peptide Science. 2019;20:750-758 [PMID: 30678628. DOI: 10.2174/1389203720666190125105401
  124. 124. Salehi M, Purnell JQ. The role of glucagon-like peptide-1 in energy homeostasis. Metabolic Syndrome and Related Disorders. 2019;17:183-191 [PMID: 30720393. DOI: 10.1089/met.2018.0088
  125. 125. Federico A, Dallio M, Tolone S, Gravina AG, Patrone V, Romano M, et al. Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: Effect of bariatric surgery. In Vivo. 2016;30:321-330 [PMID: 27107092]
  126. 126. Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, et al. Genetic determinants of the gut microbiome in UK twins. Cell Host & Microbe. 2016;19:731-743 [PMID: 27173935. DOI: 10.1016/j.chom.2016.04.017
  127. 127. Poole AC, Goodrich JK, Youngblut ND, Luque GG, Ruaud A, Sutter JL, et al. Human salivary amylase gene copy number impacts oral and gut microbiomes. Cell Host & Microbe. 2019;25:553-564.e7 [PMID: 30974084. DOI: 10.1016/j.chom.2019.03.001
  128. 128. Moeller AH, Suzuki TA, Phifer-Rixey M, Nachman MW. Transmission modes of the mammalian gut microbiota. Science. 2018;362:453-457 [PMID: 30361372. DOI: 10.1126/science.aat7164
  129. 129. Koleva PT, Kim JS, Scott JA, Kozyrskyj AL. Microbial programming of health and disease starts during fetal life. Birth Defects Research. Part C, Embryo Today. 2015;105:265-277 [PMID: 26663884. DOI: 10.1002/bdrc.21117
  130. 130. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping the human gut microbiota. Nature. 2018;555:210-215 [PMID: 29489753. DOI: 10.1038/nature25973
  131. 131. Liu MT, Huang YJ, Zhang TY, Tan LB, Lu XF, Qin J. Lingguizhugan decoction attenuates dietinduced obesity and hepatosteatosis via the gut microbiota. World Journal of Gastroenterology. 2019;25:3590-3606 [PMID: 31367159. DOI: 10.3748/wjg.v25.i27.3590
  132. 132. Poroyko VA, Carreras A, Khalyfa A, Khalyfa AA, Leone V, Peris E, et al. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Scientific Reports. 2016;6:35405 [PMID: 27739530. DOI: 10.1038/srep35405
  133. 133. Kuperman Y, Issler O, Regev L, Musseri I, Navon I, Neufeld-Cohen A, et al. Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis. Proceedings of National Academic Science USA. 2010;107:8393-8398 [PMID: 20404164. DOI: 10.1073/pnas.1003969107
  134. 134. Qiao Y, Sun J, Xia S, Tang X, Shi Y, Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food & Function. 2014b;5(6):1241-1249
  135. 135. Shen L, Liu L, Ji HF. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food & Nutrition Research. 2017a;61:1361780
  136. 136. Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. International Journal of Molecular Sciences. 2015a;16:7493-7519
  137. 137. Zhang YJ, Gan RY, Li S, Zhou Y, Li AN, Xu DP, et al. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015b;20:21138-21156
  138. 138. Klinder A, Shen Q , Heppel S, Lovegrove JA, Rowland I, Tuohy KM. Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota. Food & Function. 2016;7(4):1788-1796
  139. 139. Van Hul M, Geurts L, Plovier H, Druart C, Everard A, Ståhlman M, et al. Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier. American Journal of Physiology - Endocrinology and Metabolism. 2018;314(4):334-352
  140. 140. Condezo-Hoyos L, Mohanty IP, Noratto GD. Assessing non-digestible compounds in apple cultivars and their potential as modulators of obese faecal microbiota in vitro. Food Chemistry. 2014;161:208-215
  141. 141. Jiang TT, Gao XJ, Wu C, Tian F, Lei QC, Bi JC, et al. Apple-derived pectin modulates gut microbiota, improves gut barrier function, and attenuates metabolic endotoxemia in rats with diet-induced obesity. Nutrients. 2016;8(3):126. DOI: 10.3390/nu8030126
  142. 142. Masumoto S, Terao A, Yamamoto Y, Mukai T, Miura T, Shoji T. Nonabsorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes. Scientific Reports. 2016;6:31208
  143. 143. Heyman-Lindén L, Kotowska D, Sand E, Bjursell M, Plaza M, Turner C, et al. Lingonberries alter the gut microbiota and prevent low-grade inflammation in high-fat diet fed mice. Food & Nutrition Research. 2016;60:29993
  144. 144. Lee S, Keirsey KI, Kirkland R, Grunewald ZI, Fischer JG, de La Serre CB. Blueberry supplementation influences the gut microbiota, inflammation, and insulin resistance in high-fat-diet-fed rats. Journal of Nutrition. 2018b;148(2):209-219
  145. 145. Pan P, Lam V, Salzman N, Huang YW, Yu J, Zhang J, et al. Black raspberries and their anthocyanin and fiber fractions alter the composition and diversity of gut microbiota in F-344 rats. Nutrition and Cancer-An International Journal. 2017;69(6):943-951
  146. 146. Xing YW, Lei GT, Wu QH, Jiang Y, Huang MX. Procyanidin B2 protects against diet-induced obesity and nonalcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. World Journal of Gastroenterology. 2019;25:955-966
  147. 147. Ojo B, El-Rassi G, Payton ME, Perkins-Veazie P, Clarke S, Smith BJ, et al. Mango supplementation modulates gut microbial dysbiosis and short-chain fatty acid production independent of body weight reduction in C57BL/6 mice fed a high-fat diet. Journal of Nutrition. 2016;146(8):1483-1491
  148. 148. Tung YC, Chang WT, Li S, Wu JC, Badmeav V, Ho CT, et al. Citrus peel extracts attenuated obesity and modulated gut microbiota in mice with high-fat diet-induced obesity. Food & Function. 2018;9(6):3363-3373
  149. 149. Stenblom EL, Weström B, Linninge C, Bonn P, Farrell M, Rehfeld JF, et al. Dietary green-plant thylakoids decrease gastric emptying and gut transit, promote changes in the gut microbial flora, but does not cause steatorrhea. Nutrition & Metabolism. 2016;13:67
  150. 150. Eslinger AJ, Eller LK, Reimer RA. Yellow pea fiber improves glycemia and reduces Clostridium leptum in diet-induced obese rats. Nutrition Research. 2014;34(8):714-722
  151. 151. Panasevich MR, Schuster CM, Phillips KE, Meers GM, Chintapalli SV, Wankhade UD, et al. Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats. Journal of Nutritional Biochemistry. 2017;46:125-136
  152. 152. Nakatani A, Li X, Miyamoto J, Igarashi M, Watanabe H, Sutou A, et al. Dietary mung bean protein reduces high-fat diet-induced weight gain by modulating host bile acid metabolism in a gut microbiota-dependent manner. Biochemical and Biophysical Research Communications. 2018;501(4):955-961
  153. 153. Pan MH, Tung YC, Yang G, Li S, Ho CT. Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee. Food & Function. 2016;7(11):4481-4491
  154. 154. Liu JH, Hao WJ, He ZY, Kwek E, Zhao YM, Zhu HY, et al. Beneficial effects of tea water extracts on the body weight and gut microbiota in C57BL/6J mice fed with a high-fat diet. Food & Function. 2019;10:2847-2860
  155. 155. Seo DB, Jeong HW, Cho D, Lee BJ, Lee JH, Choi JY, et al. Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice. Journal of Medicinal Food. 2015;18(5):549-556
  156. 156. Carrera-Quintanar L, López Roa RI, Quintero-Fabián S, Sánchez-Sánchez MA, Vizmanos B, Ortuño-Sahagún D. Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases. Mediators of Inflammation. 2018:9734845
  157. 157. Zheng J, Zhou Y, Li Y, Xu DP, Li S, Li HB. Spices for prevention and treatment of cancers. Nutrients. 2016;8:495
  158. 158. Zhang Z, Chen Y, Xiang L, Wang Z, Xiao GG, Hu J. Effect of curcumin on the diversity of gut microbiota in ovariectomized rats. Nutrients. 2017a;9:1146
  159. 159. Kang C, Wang B, Kaliannan K, Wang XL, Lang HD, Hui SC, et al. Gut microbiota mediates the protective effects of dietary capsaicin against chronic lowgrade inflammation and associated obesity induced by high-fat diet. MBio. 2017;8:e00470-173
  160. 160. Shen W, Shen M, Zhao X, Zhu H, Yang Y, Lu S, et al. Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila. Frontiers in Microbiology. 2017b;8:1-10
  161. 161. Hamer HM, Jonkers D, Venema K, et al. Review article: The role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics. 2008;27(2):104-119
  162. 162. Krautkramer KA, Kreznar JH, Romano KA, et al. Diet–microbiota interactions mediate global epigenetic programming in multiple host tissues. Molecular Cell. 2016;64(5):982-992
  163. 163. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, et al. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochimica et Biophysica Acta. 2010;1:1175-1183
  164. 164. Frost G, Sleeth ML, Sahuri-Arisoylu M, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications. 2014;5:3611
  165. 165. den Besten G, van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research. 2013;54:2325-2340
  166. 166. DiBaise JK, Zhang H, Crowell MD, et al. Gut microbiota and its possible relationship with obesity. Mayo Clinic Proceedings. 2008;83(4):460-469
  167. 167. Flint HJ. Obesity and the gut microbiota. Journal of Clinical Gastroenterology. 2011;45(Suppl):S128-S132
  168. 168. Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2010;18:190-195
  169. 169. Masotti A. Interplays between gut microbiota and gene expression regulation by miRNAs. Frontiers in Cellular and Infection Microbiology. 2012;2:137. DOI: 10.3389/fcimb.2012.00137 eCollection 2012

Written By

Arslan Ahmad, Sakhawat Riaz and Muhammad Tanveer

Submitted: 24 April 2022 Reviewed: 12 May 2022 Published: 24 June 2022